Author:
Wahlgren T,Harmenberg U,Sandström P,Lundstam S,Kowalski J,Jakobsson M,Sandin R,Ljungberg B
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Aron M, Nguyen MM, Stein RJ, Gill IS (2008) Impact of gender in renal cell carcinoma: an analysis of the SEER database. Eur Urol 54: 133–140
2. Barlow L, Westergren K, Holmberg L, Talbäck M (2009) The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 48: 27–33
3. Buchler T, Klapka R, Melichar B, Brabec P, Dusek L, Vyzula R, Abrahamova J (2012) Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma--data from the Czech registry. Ann Oncol 23: 395–401
4. Swedish National Board of Health and Welfare, 2009 Cancer Incidence in Sweden 2009. Available at
http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/18204/2010–12–17.pdf
accessed 31 August 2011
5. Choueiri TK, Xie W, Kollmannsberger C, North S, Knox JJ, Lampard JG, McDermott DF, Rini BI, Heng DY (2011) The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy. J Urol 185: 60–66
Cited by
85 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献